Gan HK - Search Results

1

Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy.

Bylicki O, Gan HK, Joly F, Maillet D, You B, Péron J. Bylicki O, et al. Among authors: gan hk. Ann Oncol. 2015 Jan;26(1):231-237. doi: 10.1093/annonc/mdu489. Epub 2014 Oct 29. Ann Oncol. 2015. PMID: 25355720 Free article.

2

The reporting of adverse events in oncology phase III trials: a comparison of the current status versus the expectations of the EORTC members.

Maillet D, Blay JY, You B, Rachdi A, Gan HK, Péron J. Maillet D, et al. Among authors: gan hk. Ann Oncol. 2016 Jan;27(1):192-8. doi: 10.1093/annonc/mdv485. Epub 2015 Oct 19. Ann Oncol. 2016. PMID: 26483049 Free article.

3

Inclusion of elderly patients in oncology clinical trials.

Le Saux O, Falandry C, Gan HK, You B, Freyer G, Péron J. Le Saux O, et al. Among authors: gan hk. Ann Oncol. 2016 Sep;27(9):1799-804. doi: 10.1093/annonc/mdw259. Epub 2016 Jun 29. Ann Oncol. 2016. PMID: 27358382 Free article.

4

Changes in the use of end points in clinical trials for elderly cancer patients over time.

Le Saux O, Falandry C, Gan HK, You B, Freyer G, Péron J. Le Saux O, et al. Among authors: gan hk. Ann Oncol. 2017 Oct 1;28(10):2606-2611. doi: 10.1093/annonc/mdx354. Ann Oncol. 2017. PMID: 28961850 Free article.

5

Quality of reporting of modern randomized controlled trials in medical oncology: a systematic review.

Péron J, Pond GR, Gan HK, Chen EX, Almufti R, Maillet D, You B. Péron J, et al. Among authors: gan hk. J Natl Cancer Inst. 2012 Jul 3;104(13):982-9. doi: 10.1093/jnci/djs259. Epub 2012 Jul 3. J Natl Cancer Inst. 2012. PMID: 22761273 Review.

6

Influence of statistician involvement on reporting of randomized clinical trials in medical oncology.

Péron J, You B, Gan HK, Maillet D, Chen EX, Pond GR. Péron J, et al. Among authors: gan hk. Anticancer Drugs. 2013 Mar;24(3):306-9. doi: 10.1097/CAD.0b013e32835c3561. Anticancer Drugs. 2013. PMID: 23221738

7

Adherence to CONSORT adverse event reporting guidelines in randomized clinical trials evaluating systemic cancer therapy: a systematic review.

Péron J, Maillet D, Gan HK, Chen EX, You B. Péron J, et al. Among authors: gan hk. J Clin Oncol. 2013 Nov 1;31(31):3957-63. doi: 10.1200/JCO.2013.49.3981. Epub 2013 Sep 23. J Clin Oncol. 2013. PMID: 24062406 Review.

8

Aggregated adverse-events outcomes in oncology phase III reports: A systematic review.

Maillet D, Gan HK, Blay JY, You B, Péron J. Maillet D, et al. Among authors: gan hk. Eur J Cancer. 2016 Jan;52:26-32. doi: 10.1016/j.ejca.2015.08.025. Epub 2015 Nov 27. Eur J Cancer. 2016. PMID: 26630531 Review.

9

[Consistency in the analysis and reporting of PEPs in oncology randomized controlled trials from registration to publication: a systematic review].

Boespflug A, Gan H, Chen EX, Pond G, You B. Boespflug A, et al. Bull Cancer. 2012 Oct;99(10):943-52. doi: 10.1684/bdc.2012.1651. Bull Cancer. 2012. PMID: 23034429 Review. French.

10

Consistency in the analysis and reporting of primary end points in oncology randomized controlled trials from registration to publication: a systematic review.

You B, Gan HK, Pond G, Chen EX. You B, et al. Among authors: gan hk. J Clin Oncol. 2012 Jan 10;30(2):210-6. doi: 10.1200/JCO.2011.37.0890. Epub 2011 Dec 12. J Clin Oncol. 2012. PMID: 22162583 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters